Genelux Corporation (GNLX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Genelux Corporation (GNLX) is down 32.3% since the beginning of the year. At $3 per share, GNLX is trading 65.4% below its 52-week high of $9.

Genelux Corporation (GNLX) has returned -32.34% so far this year and 14.79% over the past 12 months.

Based on dividend-adjusted daily data since Jan 26, 2023, GNLX's average daily return is +0.16%, while the average monthly return is +4.05%. At this rate, an investment would double in approximately 1.5 years.

Historically, 48% of months were positive and 52% were negative. The best month was Feb 2023 with a return of +159.6%, while the worst month was Apr 2024 at -51.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.

On a daily basis, GNLX closed higher 47% of trading days. The best single day was Mar 6, 2023 with a return of +60.4%, while the worst single day was May 24, 2024 at -43.0%.

Genelux Corporation has an annualized alpha of 11.26%, beta of 1.45, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since January 27, 2023.

• This stock participated in 176.47% of S&P 500 Index downside but only -3.61% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

GNLX ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Genelux Corporation (GNLX) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Genelux Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Genelux Corporation was 95.74%, occurring on Aug 5, 2024. The portfolio has not yet recovered.

The current Genelux Corporation drawdown is 92.24%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Genelux Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Genelux Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.